GlassScriptPhysician profile
Brandon Helbling
NPI 1295938413
$23,001.79
in general payments reported to CMS, 2019-2025
17 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,702 · 2020: $184 · 2021: $7,573 · 2022: $8,009 · 2023: $163 · 2024: $4,147 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,804 · Education: $1,699 · Food and Beverage: $1,021 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,803.71 |
| Education | $1,699.08 |
| Food and Beverage | $1,021.06 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,682.49 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $7,312.50 | 2021-2022 | |
| Depuy Synthes Sales INC. | $3,900.00 | 2021 | |
| Ethicon US, LLC | $636.76 | 2019-2025 | Vistaseal, Surgiflo Hemostatic Matrix, Ethicon |
| Takeda Pharmaceuticals U.S.A., INC. | $121.77 | 2022 | |
| Janssen Biotech, INC. | $75.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.33 | 2022 | |
| Abbvie INC. | $39.35 | 2022 | |
| Celgene Corporation | $26.73 | 2022 | |
| Csl Behring | $24.05 | 2023 | Kcentra |
| Z-Medica, LLC | $22.93 | 2019 | |
| Novo Nordisk INC | $22.31 | 2020 | |
| Daiichi Sankyo INC. | $17.99 | 2022 | |
| Smith+Nephew, INC. | $17.50 | 2022 | |
| Amgen INC. | $15.85 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.84 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Helbling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.